Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference28 articles.
1. Natural history of Alzheimer's disease and other dementias: review of the literature in the light of the findings from the Kungsholmen Project;Aguero-Torres;Int J Geriatr Psychiatry,1998
2. Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial;Wilcock;BMJ,2000
3. Donepezil for the symptomatic treatment of patients with mild to moderate Alzheimer's disease: a meta-analysis of individual patient data from randomised controlled trials;Whitehead;Int J Geriatr Psychiatry,2004
4. Metaanalysis of randomized trials of the efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer disease;Ritchie;Am J Geriatr Psychiatry,2004
5. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting;Tariot;J Am Geriatr Soc,2001
Cited by 320 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Ageing, Proteostasis, and the Gut: Insights into Neurological Health and Disease;Ageing Research Reviews;2024-09
2. Efficacy of 5 and 10 mg donepezil in improving cognitive function in patients with dementia: a systematic review and meta-analysis;Frontiers in Neuroscience;2024-07-22
3. Succinimide Derivatives as Acetylcholinesterase Inhibitors—In Silico and In Vitro Studies;Current Issues in Molecular Biology;2024-05-22
4. Proarrhythmic major adverse cardiac events with donepezil: A systematic review with meta‐analysis;Journal of the American Geriatrics Society;2024-04-05
5. Safety and efficacy of acetylcholinesterase inhibitors for Alzheimer’s disease: A systematic review and meta-analysis;Advances in Clinical and Experimental Medicine;2024-03-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3